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PCB and PCDF Congeners in the Blood
and Tissues of Yusho and
Yu-Cheng Patients
by Yoshito Masuda,* Hiroaki Kuroki,* Koichi Haraguchi*
and Junya Nagayamat
Polychlorinated biphenyl (PCB) poisonings occurred in western Japan, where it is called Yusho, in 1968,
and in central Taiwan, where it is called Yu-Cheng, in 1979. The average concentrations of PCBs in the
adipose tissue, liver and blood of Yusho patients and in the blood of Yu-Cheng patients were 1.9 ppm, 0.08
ppm, 6.7 ppb and 99 ppb, respectively. Seven PCB congeners, such as 2,4,5,3',4'-pentachloro-, 2,3,4,3',4'-
pentachloro-, 2,4,5,2',4',5'-hexachloro-, 2,3,4,2',4',5'-hexachloro-, 2,3,4,5,3',4'-hexachloro-, 2,3,4,5,2',4',5'-
heptachloro- and 2,3,4,5,2',3',4'-heptachloro biphenyls were identified in the blood and tissues of patients
with Yusho and Yu-Cheng and controls. The concentration of 2,3,4,5,3',4'-hexachlorobiphenyl was com-
paratively higher in the patients than in controls. The concentrations of polychlorinated dibenzofurans
(PCDFs) in the adipose tissue and liver of Yusho patients were 6 to 13 ppb and 3 to 25 ppb, respec-
tively, while no PCDFs were detected in the controls. Major PCDF congeners identified in the tissues
and blood of Yusho and Yu-Cheng patients were the 2,3,6,8-tetrachloro-, 2,3,7,8-tetrachloro-, 1,2,4,7,8-
pentachloro-, 2,3,4,7,8-pentachloro- and 1,2,3,4,7,8-hexachlorodibenzofurans (DFs), ofwhich the 2,3,4,7,8-
pentachloro compound was predominant. The concentrations of methylthio-PCB in the liver, lung and
adipose tissue of Yusho patients were 0.1 to 0.5, 0.2 to 1.4 and 0.5 to 1.0 ppb, respectively, and those
of methysulfone PCBs were 0.3 to 0.7, 1.0 to 2.5 and 0.7 to 1.0 ppb, respectively. Some of the major
peaks ofthe PCB methylthio and methylsulfone derivatives were identical in gas chromatographic reten-
tion times with those of4-methylthio- and4-methylsulfone-2,5,2',5'-tetrachlorobiphenyl PCDFs, especially
2,3,4,7,8-pentachloro DF, appear to be mainly responsible in the poisonings.
Introduction
Ingestion of rice oil contaminated with polychlori-
nated biphenyls (PCBs), polychlorinated dibenzofurans
(PCDFs) and polychlorinated quaterphenyls (PCQs)
caused mass food poisoning called Yusho in western
Japan in 1968 (1-3) and Yu-Cheng in central Taiwan in
1979 (4). Yusho patients totaled 1788 at the end of 1982
and 2060 for Yu-Cheng in the beginning of 1983. They
suffered from various chronic symptoms, such as acne-
form eruptions, hypersecretion of the Meibomian glands,
hyperpigmentation of the face, eyelids, gingiva, nails
and mucous membrane, abdominal pain, headache, and
general fatigue (5).
This paper describes PCB and PCDF congeners and
sulfur-containing metabolites of PCBs retained in the
blood and tissues of Yusho and Yu-Cheng patients and
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then discusses the relationship between these conge-
ners and the etiology of symptoms of Yusho and
Yu-Cheng.
PCBs
Blood and autopsy tissues from the patients with
Yusho were analyzed for PCBs by saponification in 1N
NaOH ethanol solution, extraction with n-hexane,
column chromatography on silica gel, and then gas
chromatography with electron capture detection. The
concentrations (mean + SD) of PCBs in the adipose
tissue, liver and blood of Yusho patients about 5 years
afterthe outbreak (6,7) were 1.9± 1.4 ppm (N = 9), 0.08
+ 0.06 ppm (N = 8) and 6.7 ± 5.3 ppb (N = 41),
respectively. These values were only about twice those
of controls. The blood PCB level of some of Yu-Cheng
patients was 99 ± 163 ppb (N = 23) (8) and much higher
than that ofcontrols from the Taiwanese population (1.2
± 0.7 ppb, N = 29) and the value of Yusho patients
described above. The difference in PCB levels in YushoMASUDA ET AL.
and Yu-Cheng patients is probably due to the timing of
sampling, being about 5 years after exposure for Yusho
and 1 year for Yu-Cheng. The PCB fractions from the
blood of Yusho and Yu-Cheng patients were also gas
chromatographed on an efficient Apiezon L column (5
m) to identify main PCB congeners in the blood.
Figures 1 and 2 show gas chromatograms ofPCBs from
the adipose tissue and blood of Yusho and Yu-Cheng
patients. Individual peaks were identified for PCB
structures by comparing their retention times with
those of authentic PCB congeners and by obtaining
their spectra by gas chromatography-mass spectrome-
try (8,9). The structures of individual PCBs and their
concentrations in the blood of Yusho and Yu-Cheng
patients are listed in Thble 1. The concentrations of
individual PCBs in the blood were characteristically
different between Yusho patients and normal persons.
In the blood of Yusho patients, the concentration of
2,4,5,3',4'-pentachlorobiphenyl, corresponding to peak
1, was lower than that of normal persons, while the
concentration of 2,3,4,5,3',4'-hexachlorobiphenyl, cor-
responding to peak 5, was higher. This characteristic
difference in gas chromatographic pattern has been
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FIGURE 1. Gas chromatograms ofPCBs on 1.5% Apiezon L column
(5 m): (A) from adipose tissue of Yusho patient; (B) from adipose
tissue of nonexposed control; (C) sample of Kanechlor 600. PCB
structures of the numbered peaks are given in Table 1. Data of
Kuroki and Masuda (9).
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FIGURE 2. Gas chromatograms ofPCBs on 1.5% Apiezon L column
(5 m): (A,B) from the blood of Yu-Cheng patients; (C) sample of
Kanechlor 500. PCB structures ofthe numbered peaks are given in
Table 1. Data of Masuda et al. (8).
Table 1. Concentrations of PCB congeners in the blood of patients with Ysho and Yu-Cheng (Fukuoka and Taiwan).
Concentration of PCBs in blood, ppba Fukuoka Fukuoka Fukuoka
Fukuoka, Fukuoka, Taiwan, Yusho: Yu-Cheng: Yu-Cheng:
Peak PCB control Yusho patient Yu-Cheng patient Fukuoka Fukuoka Fukuoka
no. assigned (N= 7) (N = 9) (N = 10) controls controls Yusho
1 2,4,5,3',4'- 0.22 ± 0.09 0.13 ± 0.05 3.46 ± 2.37 0.59 16 27
Penta-CB
2 2,3,4,3',4'- 0.05 ± 0.02 NDb 1.20 ± 1.03 24
Penta-CB
3 2,4,5,2',4',5'- 0.15 ± 0.07 0.52 ± 0.22 2.51 ± 0.96 3.5 17 4.8
Hexa-CB
4 2,3,4,2',4',5'- 0.17 + 0.07 0.65 ± 0.21 4.66 ± 1.43 3.8 27 7.2
Hexa-CB
5 2,3,4,5,3',4'- 0.04 ± 0.02 0.28 ± 0.07 1.79 ± 0.69 7.0 45 6.4
Hexa-CB
6 2,3,4,5,2',4',5'- 0.12 ± 0.07 0.44 ± 0.15 1.73 ± 0.63 3.7 14 3.9
Hepta-CB
7 2,3,4,5,2',3',4'- 0.11 ± 0.04 0.28 ± 0.09 1.18 ± 0.45 2.5 11 4.2
Hepta-CB
Ibtal 0.86 2.3 16.53 2.7 19 7.2
aMean ± SD
bND = not detected<0.01 ppb.
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adopted as one of the criteria for diagnosis of Yusho
(10). In the blood ofYu-Cheng patients, the concentra-
tion of 2,4,5,3',4'-pentachlorobiphenyl was relatively
high, as shown in Figure 2. However, its concentration
graduallydecreased withtime, changingitsgas chroma-
tographic pattern to that of typical Yusho. Relatively
high concentrations of 2,3,4,5,3',4'-hexachlorobiphenyl
wereobservedinthebloodofYu-Chengpatients(Thble 1).
According to the biological activity tests in the rats
pretreated with PCB congeners (11), of the PCB
congeners identified in the patients, 2,3,4,5,3',4'-hexa-
chlorobiphenyl showed the highest enzyme-inducing
activity on benzo[a]pyrene hydroxylase and DT-dia-
phorase in the rat liver homogenates and caused most
of the marked atrophy of the thymus and hypertrophy
of the liver in the rats.
Considering the high accumulation in the patients
and the strong biological activity, 2,3,4,5,3',4'-hexa-
chlorobiphenyl is the PCB congener most closely corre-
lated with the occurrence of symptoms of Yusho and
Yu-Cheng.
PCDFs
The adipose tissue and liver of deceased Yusho
patients were analyzed for PCDFs by gas chromatogra-
phy with electron capture detection afterthe separation
of PCBs and PCDFs by column chromatography on
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alumina. The individual gas chromatographic peaks
were confirmed to be PCDFs by gas chromatography-
mass spectrometry as shown in Figure 3 and mass
fragmentography. The concentrations of PCDFs in the
adipose tissue and liverwereinranges of6to 13 and 3 to
25 ppb, respectively. No PCDFs were detected at the
detection limit of0.005 ppb in the same tissues obtained
at autopsy from persons who had been killed in traffic
accidents (12). The PCDF concentrations in the adipose
tissue and liver ofYusho patients were on similarlevels,
whereas the concentration ofPCBs in the adipose tissue
was more than ten times that in the liver. These results
indicate that PCDFs are more retainable in the liver
than PCBs.
The PCDF fractions separated from the tissues of
Yusho patients were further determined by gas chroma-
tography and mass fragmentography with more effi-
cient columns for identifying PCDF congeners. A glass
column (5 m) packed with 1.5% Apiezon L (13) and a
fused silica capillary column coated with OV-101 (Fig. 4)
were used for the gas chromatography, and a glass
capillary column coated with OV-17 was for the mass
fragmentography(14). IndividualPCDFcongenerswere
identified by comparing theirretention times with those
of corresponding authentic PCDF congeners. Table 2
lists the concentrations of PCDF congeners in the
adipose tissue and liver of Yusho patients. Among the
several PCDF congeners identified, 2,3,7,8-tetrachloro-
dibenzofuran (DF) was determined to be at low levels,
while 2,3,4,7,8-pentachloro-DF was predominant even
in the tissues of the patient who died 9 years after
the outbreak (13). The adipose tissue and liver ofa baby
who was born to a mother with Yu-Cheng and the blood
of Yu-Cheng patients were also analyzed for PCDF
congeners by mass fragmentography (15). The results
are summarized in Table 3. Similar to the PCDF
congeners in Yusho patients, relatively low concentra-
tion of 2,3,7,8-tetrachloro-DF and high concentrations
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FIGURE 3. Gas chromatography-mass spectra of PCDF fractions:
(A,C) tissue from liver ofYusho patients; (B) synthesized PCDFs;
(D) sample of contaminated rice oil.
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FIGURE 4. Gas chromatogram of PCDF fraction of tissue from the
liver of a Yusho patient. Column; fused silica capillary coated with
OV-101, 5 m; oven temperature, 180-250°C; rate of rise 2°C/min;
electron capture detector.
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of 2,3,4,7,8-pentachloro-DF and 1,2,3,4,7,8-hexa-
chloro-DF were also observed in the Yu-Chengpatients,
althoughthehighconcentrationof1,2,3,7,8-pentachloro-
DF in Yu-Cheng patients was in contrast with its low
concentration in Yusho patients.
About 40 PCDF congeners were identified in the rice
oil which was ingested by Yusho patients (16). Some of
them, such as 2,3,6,7-tetrachloro-, 2,3,4,6,7-pentachlo-
ro-, 1,2,6,7,8-pentachloro-, 1,2,3,4,8-pentachloro-, and
1,2,3,4,6,7-hexachloro-DF, were, however, not identified
in the tissues of the patients. These congeners were
relatively easily metabolized and excreted, since they
have two adjacent carbon atoms not substituted with
chlorine atoms in the dibenzofuran ring. In contrast
with these congeners, the PCDF congeners retained in
the body for a long time, such as 2,3,6,8-tetrachloro-,
2,3,7,8-tetrachloro-, 1,2,4,7,8-pentachloro, 2,3,4,7,8-
pentachloro-, and 1,2,3,4,7,8-hexachloro-DF, donothave
such adjacent carbon atoms (14).
The individual PCDF congeners identified in the
patients with Yusho and Yu-Cheng were synthesized
and purified by recrystallization and/or high perfor-
mance liquid chromatography and subjected to tests of
biological activity and retention. Most of the PCDF
congeners showed strong enzyme-inducing activities on
benzo[a]pyrene hydroxylase and DT-diaphorase and
caused severe atrophy of the thymus and significant
hypertrophy of the liver in the treated rats (17,18).
Above all, a dose-response study of 2,3,4,7,8-penta-
chloro-DF, the PCDF congener retained to the highest
extent in patients with Yusho and Yu-Cheng, demon-
strated thattheminimum dosages ofthis congener were
1 ,ug/kg for the inductive effects and 10 ,ug/kg for gravi-
metric changes ofthe tissues (17). The high accumulat-
ing tendency of2,3,4,7,8-pentachloro-DF in the liver of
the patients was also confirmed by animal experiments in
rats and monkeys (19). Considering all these aspects,
we cannot disregard these PCDFs, especially 2,3,4,7,8-
pentachloro-DF, as the most important etiologic agents
for symptoms of Yusho and Yu-Cheng.
Sulfur-Containing Metabolites of
PCBs
Methylsulfone metabolites of PCBs are known to be
persistent compounds in the tissues of humans and
animals (20,21). Therefore, liver, lung and adipose
tissue of Yusho patients was analyzed for methylthio
andmethylsulfone derivatives ofPCBsby gas chromato-
graphy, gas chromatography-mass spectrometry and
mass fragmentography after column chromatography
Table 2. Concentrations of PCBs and PCDF congeners in the liver and adipose tissue of Yusho patients.a
Concentration Concentration of PCDFs (ppb)b Ratio
Time of PCBs, PCDFsx 100
Case of death Tissue ppm A B C D E Total PCBs
1 July 1969 Liver 0.14 0.7 0.3 7.1 6.9 2.6 17.6 13
2 July 1969 Liver 0.2 0.08 0.02 0.4 1.2 0.3 2.0 1
Adipose 2.8 0.6 0.3 1.0 5.7 1.7 9.3 0.3
3 May 1972 Liver 0.03 0.03 Trec 0.09 0.3 0.03 0.45 1.5
Adipose 4.3 0.08 NDd 0.2 0.8 0.2 1.28 0.03
4 April 1975 Adipose 0.2 0.4 ND 0.8 0.1 0.5 1.8 0.9
5 March 1977 Liver 0.006 ND ND 0.02 0.1 0.04 0.16 2.7
Adipose 1.2 ND ND 0.2 0.5 ND 0.7 0.06
aData of Kuroki and Masuda (13).
bCompounds: (A) 2,3,6,8-tetrachloro-DF; (B) 2,3,7,8-tetrachloro-DF; (C) 1,2,4,7,8-pentachloro-DF; (D) 2,3,4,7,8-pentachloro-DF; (E) 1,2,3,4,
7,8-hexachloro-DF + 1,2,3,6,7,8-hexachloro-DF.
'Tr = 0.005-0.01 ppb.
dND = not detected (<0.005 ppb).
Table 3. Concentration ofPCBs and PCDF congeners in the tissues ofYu-Cheng infant and the blood ofYu-Cheng and Yusho patients.a
Yu-Cheng Yusho,
Baby Blood blood
Patient Patient Patient Patient
Adipose tissue Liver A B A B
Tbtal PCBs, ppb 316 27 740 310 4 5
2,3,7,8-Tetrachloro-DF, ppt 17 60 <30b <30b <30b <30b
1,2,4,7,8-Pentachloro-DF, ppt 14 42 60 40 NDC ND
1,2,3,7,8-Pentachloro-DF, ppt 44 194 30 20 ND ND
2,3,4,7,8-Pentachloro-DF, ppt 68 91 120 80 3 3
1,2,3,4,7,8-Hexachloro-DF, ppt 88 193 150 60 <6b <bb
Tbtal PCDFs, ppt 231 580 360 200 3 3
aRappe et al. (15).
bLess than detection limit.
CND = not detected.
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on silica gel, partition between n-hexane and sulfuric
acid and high performance liquid chromatography (22).
The methylthio-PCB fraction showed two peaks on gas
chromatography and mass fragmentography corres-
ponding to methylthio PCB derivatives. One ofthe two
peaks was identical in retention time with that of
4-methylthio-2,5,2',5'-tetrachlorobiphenyl. Gaschroma-
tography, gas chromatography-mass spectrometry and
mass fragmentography of the methylsulfone PCB frac-
tions showed at least 16 peaks corresponding to methyl-
sulfone PCBs with three to six chlorine atoms. Some
of the mass spectra are shown in Figure 5. One of
the major peaks was assigned to 4-methylsulfone-
2,5,2',5'-tetrachlorobiphenyl by the retention times in
gas chromatography and mass fragmentography.
As summarized in Table 4, the levels of methylthio
chlorinated biphenyls in the liver, lung and adipose
tissue of Yusho patients were 0.1 to 0.5, 0.2 to 1.4 and
0.5 to 1.0 ppb, respectively, and those of the methyl-
sulfone PCBs were 0.3 to 0.7, 1.0 to 2.5 and 0.7 to 1.0
ppb, respectively, whereas the levels of PCBs in these
tissues were estimated as 28 to 100, 18 to 66 and 880 to
2200 ppb, respectively. The ratios of the levels of
methylthio and methylsulfone PCBs to that of PCBs
were, therefore, 1 to 2% in the liver, 4 to 8% in the lung
and 0.1 to 0.2% in the adipose tissue. The sulfur-
containing metabolites of PCBs tended to accumulate
more readily in the lung and liver than in the adipose
tissue. The methylthio and methylsulfone PCBs present
in the tissues ofthe patients should be studied to assess
their toxic potencies and to evaluate the connection of
these compounds with the symptoms of Yusho.
Discussion
The PCB level in the blood ofYusho patients was 6.7
ppb, on the average, only about twice that of controls.
Some workers occupationally exposed to PCBs had
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FIGURE 5. Gas chromatography-mass spectra ofPCB methylsulfone
fractions: (A,C) tissues from the lung of Yusho patients; (B)
2,5,4'-trichlorobiphenyl-4-methylsulfone, (D) 2,5,2'5'-tetrachloro-
biphenyl-4-methylsulfone.
Table 4. Levels ofPCBs, methylthio-PCBs and PCB-methylsulfones in the liver, lung and adipose tissue ofYusho patients and controls.
Methylthio PCB Ratio of methylthio-
PCBs, PCBs, methylsulfones, PCB + PCB-methylsulfones: PCBs
Case Tissue ppb ppb ppb ( x 100), %
Yusho patients
1 Liver 45 0.5 0.4 2.0
Lung 66 1.4 1.1 3.8
Adipose 880 0.5 0.7 0.1
2 Liver 100 0.5 0.7 1.2
Lung 18 0.4 1.0 7.7
Adipose 2170 1.0 0.8 0.1
3 Liver 28 0.1 0.3 1.4
Lung 56 0.2 2.5 4.8
Adipose 970 1.0 1.0 0.2
Controls
4 Liver 9 NDa 0.05 0.6
Lung 7 0.07 0.2 3.9
Adipose 160 ND 0.2 0.1
5 Liver 56 ND 0.04 0.07
Lung 18 0.05 0.9 5.2
Adipose 180 ND 0.05 0.03
'ND = not detected (<0.01 ppb).
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more than 100 ppb of PCBs in the blood (23). However,
the workers showed no typical symptoms of Yusho or
mild and benign clinical signs, while the patients with
Yusho have been suffering from various Yusho symp-
toms formore than 15years. This discrepancy cannot be
fully explained by the difference in the blood PCB levels
amongthe Yushopatients, occupationally exposedwork-
ers and nonexposed controls.
PCDF congeners were definitely identified in the
blood and tissues of Yusho and Yu-Cheng patients,
while no PCDFs were detected in the tissues ofnormal
persons (12-15). These PCDF congeners, especially
2,3,4,7,8-tetrachloro-DF were highly likely to accumu-
late in the liver of humans, monkeys and rats and
showed severetoxicity, producingatrophyofthethymus,
hypertrophy of the liver and strong enzyme-inducing
activities even at very low doses (1-10 ,ug/kg) (17-19).
By an epidemilogical study of the consumption of the
rice oil by the patients with Yusho and the levels of
PCDFs in the oil, the patients were calculated to have
consumed 3.4 mg of PCDFs, on the average (24),
corresponding to a PCDF intake of 68 ,ug/kg on assum-
ing the average body weight to be 50 kg. The total
PCDF intake is therefore considered to be enough to
cause some symptoms of Yusho. The PCDF congeners
ingested by the patients would be mainly responsible in
the poisonings of Yusho and Yu-Cheng.
In evaluating causal agents for Yusho, polychlori-
nated quaterphenyls (PCQs) should be taken into
consideration, because PCQs were ingested by the
patients with Yusho and Yu-Cheng at levels comparable
with PCBs (23-24). However, PCQs might not be
important causal agents to develop the symptoms of
Yusho and Yu-Cheng (23). Further study is necessary
to clarify this relationship.
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